Communications publiées lors de congrès ou colloques nationaux et internationaux (10)

  1. 4. Heikkilä, H., Kraft, E., Jespers, P., McEntee, K., Rajamäki, M. M., & Clercx, C. (2010). Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis, chronic bronchitis and eosinophilic bronchopneumopathy. Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis, chronic bronchitis and eosinophilic bronchopneumopathy. Vol. 24 (p. 1557) European College of Veterinary Internal Medicine Congress(Septembre 2010: Toulouse).
  2. 5. Heikkilä, H., Kraft, E., Jespers, P., McEntee, K., Rajamäki, M. M., & Clercx, C. (2010). Elevation of procollagen type III concentration in bronchoalveolar lavage fluid of dogs with idiopathic pulmonary fibrosis. Elevation of procollagen type III concentration in bronchoalveolar lavage fluid of dogs with idiopathic pulmonary fibrosis. Vol. 24 (p. 703) American College of Veterinary Internal Medicine Congress(juin 2010: Anaheim).
  3. 6. Krafft, E., Heikkilä, H., Jespers, P., McEntee, K., Day, M. J., Peeters, D., Rajamäki, M. M., & Clercx, C. (2010). Endothelin-1 as a serum biomarker in iodiopathic pulmonary fibrisos in dogs. Endothelin-1 as a serum biomarker in iodiopathic pulmonary fibrisos in dogs. Vol. 24 (p. 1557) European College of Veterinary Internal Medicine Congress(Septembre 2010: Toulouse).
  4. 7. Krafft, E., Heikkilä, H., Jespers, P., McEntee, K., Peeters, D., Rajamäki, M. M., & Clercx, C. (2010). Serum endothelin-1 concentration in Terrier dogs with idiopathic pulmonary fibrosis. Serum endothelin-1 concentration in Terrier dogs with idiopathic pulmonary fibrosis. Vol. 24 (p. 700) American College of Veterinary Internal Medicine Congress, .(juin 2010: Anaheim).
  5. 8. Mahmoudabady, M., Mathieu, M., Dewachter, L., Hadad, I., Ray, L., Jespers, P., Brimioulle, S., Naeije, R., & McEntee, K. (2008). Activin-A signalling in experimental dilated cardiomyopathy. Activin-A signalling in experimental dilated cardiomyopathy. Vol. 63 (p. 87) Belgian Society of Cardiology(Février 2008: Brussels, Belgium).
  6. 9. Ray, L., Mathieu, M., Andrianne, M., Hadad, I., Mahmoudabady, M., Jespers, P., Motte, S., Peters, I. P., Naeije, R., & McEntee, K. (2007). Cardiac and pulmonary VEGF signaling in experimental dilated cardiomyopathy. Cardiac and pulmonary VEGF signaling in experimental dilated cardiomyopathy. Vol. 37 (p. 658) Physiological Joint Meeting(Septembre 2007: Bratislava).
  7. 10. Mahmoudabady, M., Ray, L., Mathieu, M., Dewachter, C., Hadad, I., Jespers, P., Naeije, R., & McEntee, K. (2007). Myostatin and IGF-1 pathways in relation with apoptosis in experimental non ischemic dilated cardiomyopathy. Myostatin and IGF-1 pathways in relation with apoptosis in experimental non ischemic dilated cardiomyopathy. Vol. 52 (p. 658) Physiological Joint Meeting(Septembre 2007: Bratislava).
  8.   Participations à des congrès et colloques internationaux (33)

  9. 1. Sheikh Mohammad, U., Hubesch, G., Van Eycken, M., Rorive, S., Nortier, J., El Fahsi, B., Singh, S. P., Vegh, G., Jespers, P., Hupkens, E., McEntee, K., Vachiery, J.-L., Dewachter, C., & Dewachter, L. (2024). Early renal anomalies in experimental HFpEF associated with multiple comorbidities. Abstract session presented at Belgian Society of Cardiology (BSC 2024)(9/02/2024: Brussels, Belgium)
  10. 2. Sheikh Mohammad, U., Hubesch, G., Van Eycken, M., Rorive, S., Nortier, J., El Fahsi, B., Vegh, G., Singh, S. P., Hupkens, E., Jespers, P., McEntee, K., Vachiery, J.-L., Dewachter, C., & Dewachter, L. (2023). Characterization of renal anomalies in an experimental model of heart failure with preserved ejection fraction (HFpEF) in rats. Poster présenté à la conférence Basic Science Research in Cardiology (07-12-2023: Ku Leuven, Leuven, Belgium).
  11. 3. Hubesch, G., Hanthazi, A., Acheampong, A., Watu Malu Wembonyama, C., Hupkens, E., Jespers, P., Vegh, G., McEntee, K., & Dewachter, L. (2021). Obesity-prone rats fed with high fat diet as a model of HFpEF. Poster présenté à la conférence Belgian Working Group Basic Research in Cardiology (BWGBRC) (2021-06-09: Belgium).
  12. 4. Hubesch, G., Hanthazi, A., Acheampong, A., Watu Malu Wembonyama, C., Hupkens, E., Jespers, P., Vegh, G., McEntee, K., & Dewachter, L. (2021). Obese prone rats fed with high fat diet as a model of HFpEF. Poster présenté à la conférence Belgian Society of Cardiology (40: 2021-02-11: Brussels, Belgium).
  13. 5. Hubesch, G., Hanthazi, A., Acheampong, A., Watu Malu Wembonyama, C., Jespers, P., Vegh, G., Verhoeven, C., Dewachter, L., & McEntee, K. (2019). Respective roles of genetic background and high fat diet in a rodent model of metabolic syndrome. Poster présenté à la conférence Printemps de la Cardiologie (Avril 2019: Lille, France).

  14. << Précédent 1 2 3 4 5 6 Suivant >>